🇺🇸 FDA

Intelligence · Patent portfolio

Disc Medicine Patents

Full USPTO pharma patent portfolio for Disc Medicine — grant dates, expiration, and drug cross-links.

Patents
706
Expiring ≤24m
26

Quick answer

Disc Medicine has 706 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 26 expire within 24 months — use filters for patent-cliff planning.

Page 9 of 15

  1. US 9809604

    DGAT1 inhibitor and preparation method and use thereof

    Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9790215

    Pyridazinone compounds and methods for the treatment of cystic fibrosis

    Expires Mon Oct 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9783578

    Immunosuppression modulating compounds

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9783529

    Pyridazinone compounds and methods for the treatment of cystic fibrosis

    Expires Mon Oct 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9777024

    Heteroaryl inhibitors of PDE4

    Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9776978

    1,3,4-oxadiazole and 1,3,4-thiadiazole derivatives as immunomodulators

    Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9771338

    1,2,4-oxadiazole derivatives as immunomodulators

    Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9771327

    Compounds and methods for the treatment of cystic fibrosis

    Expires Mon Sep 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9758529

    Fused dihydro-4H-pyrazolo[5,1-C][1,4]oxazinyl compounds and analogs for treating CNS disorders

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9757424

    Compositions and methods of treating gliomas

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9745572

    Method for identifying antibiotic targets

    Expires Mon Aug 24 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9732095

    Bicyclic heterocyclyl derivatives as IRAK4 inhibitors

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9731037

    Scanning suspension comprising a particle with a diameter of at least 1 micrometer

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9714244

    Substituted pyrido[4,3-d]pyrimidines as Wee-1 inhibitors

    Expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9707215

    Inhibitors of hepatitis C virus polymerase

    Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9682969

    Phthalazinone compounds and methods for the treatment of cystic fibrosis

    Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9677143

    Compositions and methods for the identification of inhibitors of retroviral infection

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9676779

    Small molecule CFTR correctors

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9670177

    Crystalline C21H22Cl2N4O2 malonate

    Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9657270

    Human disc tissue

    Expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9642898

    Use of serine protease inhibitors in the treatment of neutropenia

    Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9630932

    Trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors

    Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 9623055

    Method for preventing and/or treating insulin resistance

    Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 9597353

    Redox signaling gel formulation

    Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 9598414

    Substituted benzo[5,6]azepino[3,2,1-hi]pyrido[4,3-b]indoles and substituted benzo[6,7][1,4]oxazepino[2,3,4-hi]pyrido[4,3-b]indoles for treating CNS disorders

    Expires Mon Mar 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 9580438

    Bifluorodioxalane-amino-benzimidazole kinase inhibitors for the treatment of cancer, autoimmuneinflammation and CNS disorders

    Expires Mon Feb 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 9573948

    Triazolopyridine compounds and methods for the treatment of cystic fibrosis

    Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 9567345

    Pharmaceutically active pyrazolo-triazine derivatives

    Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 9546176

    Small molecule bicyclic and tricyclic CFTR correctors

    Expires Mon Jan 12 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 9522112

    System, method, and kit for selecting and preparing customized cosmetics

    Expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 9517228

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 9517222

    Method for the treatment of senile dementia of the Alzheimer's type

    Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 9493770

    Method for identifying antibiotic targets by complemented sequencing

    Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 9487753

    Compositions of adult disc stem cells and methods for the treatment of degenerative disc disease

    Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 9486481

    Method of modulating fatty acid mobilization and oxidation

    Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 9474768

    Lubricant formulations

    Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 9453051

    Cyclosporin derivatives

    Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 9446072

    Methods of ameliorating oxidative stress by increasing the efficiency of GPX and SOD activity

    Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 9433650

    Method for preventing and/or treating insulin resistance

    Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 9422339

    Immunomodulating cyclic compounds

    Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 9408844

    Methods for treating inflammatory conditions

    Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 9402830

    Methods of treating dyskinesia and related disorders

    Expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 9381228

    FKBP-L and uses thereof

    Expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 9375474

    Compounds useful for inhibiting metastasis from cancer and methods using same

    Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 9353107

    3-(pyrazolyl)-1H-pyrrolo[2,3-b]pyridine derivatives as kinase inhibitors

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 9351954

    Multicyclic compounds and methods of use thereof

    Expires Mon May 26 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 9334235

    Plasmalogen compounds, pharmaceutical compositions containing the same and methods for treating diseases of the aging

    Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 9328200

    Branched polymeric quaternary ammonium compounds and their uses

    Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Disc Medicine have?

706 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Disc Medicine patents expire?

26 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.